The polygenic UAB36 score constructed from the correlation coefficient of transcriptomics in breast cancer cell lines using patient tumor gene expression was effective at predicting tamoxifen response in ER+/HER2-breast cancer patients. The gene discussed is ERBB2; the disease is breast carcinoma.